Abstract Myocardial infarction (MI) is one of the major causes of death and disability in the world and involves complex pathological processes. Ginsenosides, the active ingredient of ginseng, have been extensively studied, which can prevent MI through multiple approaches and multiple targets, and have a good protective effect on the cardiovascular system. In this review, the relevant mechanisms of ginsenosides action in the prevention and treatment of MI are elaborated from aspects of myocardial cell apoptosis, inflammatory response, myocardial fibrosis, cardiac angiogenesis, cardiac remodeling, oxygen / glucose supply, etc., in order to provide a reference for the development of new drugs for the prevention and treatment of MI by ginsenosides.
ZHAO Tingyao XU Yan. Research progress on the mechanism of ginsenoside action in the prevention and treatment of myocardial infarction#br#[J]. 中国医药导报, 2022, 19(4): 49-51,61.
[1] 中华医学会心血管病学分会，中华心血管病杂志编辑委员会.急性ST段抬高型心肌梗死诊断和治疗指南（2019）[J].中华心血管病杂志，2019，47（10）：766-783.
[2] 中华医学会心血管病学分会.血管紧张素转换酶抑制剂在冠心病患者中应用中国专家共识[J].中国循环杂志，2016，31（5）：420-425.
[3] 何奔，韩雅玲.中国ST段抬高型心肌梗死救治现状及应有对策[J].中华心血管病杂志，2019，47（2）：82-84.
[4] 赵英利，邓兵.心肌梗死后心室重构的机制及中医药防治进展[J].中西医结合心脑血管病杂志，2019，17（2）：211-215.
[5] 宋齐.人参主要化学成分及皂苷提取方法研究进展[J].人参研究，2019，31（4）：43-46.
[6] 蔡晓月，赵英强.人参治疗心血管疾病的药理学研究[J].长春中医药大学学报，2012，28（1）：158-159.
[7] Chen X，Wang Q，Shao M，et al. Ginsenoside Rb3 regulates energy metabolism and apoptosis in cardiomyocytes via activating PPARalpha pathway [J]. Biomed Pharmacother，2019，120：109487.
[8] Yan X，Liu J，Wu H，et al. Impact of miR-208 and its Target Gene Nemo-Like Kinase on the Protective Effect of Ginsenoside Rb1 in Hypoxia/Ischemia Injuried Cardiomyocytes [J]. Cell Physiol Biochem，2016，39（3）：1187-1195.
[9] Cao L，Gao Y，Zhu J，et al. Protective action of the ginsenoside Rh3 in a rat myocardial ischemia-reperfusion injury model by inhibition of apoptosis induced via p38 mitogen-activated protein kinase/caspase-3 signaling [J]. J Int Med Res，2020，48（12）：1220768642.
[10] Sun J，Sun G，Meng X，et al. Ginsenoside RK3 Prevents Hypoxia-Reoxygenation Induced Apoptosis in H9c2 Cardiomyocytes via AKT and MAPK Pathway [J]. Evid Based Complement Alternat Med，2013，2013：690190.
[11] Ruparelia N，Godec J，Lee R，et al. Acute myocardial infarction activates distinct inflammation and proliferation pathways in circulating monocytes，prior to recruitment，and identified through conserved transcriptional responses in mice and humans [J]. Eur Heart J，2015，36（29）：1923-1934.
[12] Prabhu SD，Frangogiannis NG. The Biological Basis for Cardiac Repair After Myocardial Infarction：From Inflammation to Fibrosis [J]. Circ Res，2016，119（1）：91-112.
[13] Sun GZ，Meng FJ，Cai HQ，et al. Ginsenoside Rg3 protects heart against isoproterenol-induced myocardial infarction by activating AMPK mediated autophagy [J]. Cardiovasc Diagn Ther，2020，10（2）：153-160.
[14] Tu C，Wan B，Zeng Y. Ginsenoside Rg3 alleviates inflammation in a rat model of myocardial infarction via the SIRT1/NF-kappaB pathway [J]. Exp Ther Med，2020，20（6）：238.
[15] 杨伟，滕林，丁家望，等.人参皂苷compound K对小鼠心肌梗死后心室重构的保护及免疫机制研究[J].心肺血管病杂志，2016，35（6）：478-481.
[16] 贺欣，张英杰.人参皂苷Rg1通过NF-κB通路减轻大鼠心肌缺血再灌注损伤[J].中药药理与临床，2015，31（4）：16-19.
[17] Li X，Xiang N，Wang Z. Ginsenoside Rg2 attenuates myocardial fibrosis and improves cardiac function after myocardial infarction via AKT signaling pathway [J]. Biosci Biotechnol Biochem，2020，84（11）：2199-2206.
[18] 韩凌，张晶晶，秦立.人参皂苷Rb3通过Neuregulin-1/ErbB信号通路对心肌梗死大鼠VE-cadherin，NRG-1，ErbB2，ErbB4表达的影响[J].中国循证心血管医学杂志，2019，11（2）：195-199.
[19] 彭程飞，李佳，田孝祥，等.人参皂苷Rg1抑制大鼠急性心肌梗死后心肌纤维化[J].现代生物医学进展，2017， 17（16）：3005-3007.
[20] 彭程飞，田孝祥，刘丹，等.人参皂苷Rg1促进大鼠急性心肌梗死后血管新生[J].现代生物医学进展，2019，19（14）：2638-2641.
[21] 陈协辉，梁进杰，刘新荪，等.人参皂苷Rg1对大鼠心肌梗死后心肌血管再生的影响[J].心血管康复医学杂志，2017，26（3）：245-250.
[22] Yin H，Liu Z，Li F，et al. Ginsenoside-Rg1 enhances angiogenesis and ameliorates ventricular remodeling in a rat model of myocardial infarction [J]. J Mol Med（Berl），2011，89（4）：363-375.
[23] Yu Y，Sun J，Liu J，et al. Ginsenoside Re Preserves Cardiac Function and Ameliorates Left Ventricular Remodeling in a Rat Model of Myocardial Infarction [J]. J Cardiovasc Pharmacol，2020，75（1）：91-97.
[24] Wang QW，Yu XF，Xu HL，et al. Ginsenoside Re Attenuates Isoproterenol-Induced Myocardial Injury in Rats [J]. Evid Based Complement Alternat Med，2018，2018：8637134.
[25] Lim KH，Lim DJ，Kim JH. Ginsenoside-Re ameliorates ischemia and reperfusion injury in the heart：a hemodynamics approach [J]. J Ginseng Res，2013，37（3）：283-292.
[26] Jiang M，Kang L，Wang Y，et al. A metabonomic study of cardioprotection of ginsenosides，schizandrin，and ophiopogonin D against acute myocardial infarction in rats [J]. BMC Complement Altern Med，2014，14：350.
[27] 《中成药治疗优势病种临床应用指南》标准化项目组.中成药治疗冠心病临床应用指南（2020年）[J].中西医结合心脑血管病杂志，2021，19（9）：1409-1435.
[28] 心血管网.心肌梗死中西医结合诊疗指南[J].中国中西医结合杂志，2018，38（3）：272-284.
[29] 刘群，吴然，吕超，等.麝香保心丸中5种人参皂苷类化合物在心肌梗死大鼠血浆中的药代动力学研究[J].中国中药杂志，2017，42（1）：162-169.
[30] Wang YQ，Zhang JQ，Liu CH，et al. Screening and identifying the myocardial-injury protective ingredients from Sheng-Mai-San [J]. Pharm Biol，2013，51（10）：1219-1227.
[31] Wang X，Meng H，Wang Q，et al. Baoyuan decoction ameliorates apoptosis via AT1-CARP signaling pathway in H9C2 cells and heart failure post-acute myocardial infarction rats [J]. J Ethnopharmacol，2020，252：112536.
